Michael Sharpe is a British psychiatrist and academic, specialising in the psychiatric aspects of medical illness.
[3] While a Professor at Oxford, Sharpe ran a research programme to develop and evaluate psychiatric treatments for medically ill patients.
[4] Sharpe is best known as a co-author on the controversial PACE trial which found exercise and cognitive behavioural therapy to be “moderately effective” treatments for Myalgic Encephalomyelitis.
[5] In 2021 he controversially gave a presentation on secondary covid 19 impacts[6] to Swiss Re in which he suggested that Long COVID was partly caused by psychological and social factors such as reportage by the Guardian columnist George Monbiot.
[7] Sharpe's recent work is on depression in people with cancer and the mental health of elderly inpatients.